Sterlington PLLC

Partner and Co-Head, Intellectual Property

Brian Slater is a Life Sciences and IP partner and Co-Head of Sterlington’s Intellectual Property practice. He is a lead trial lawyer who has represented pharmaceutical, biotechnology and other technology innovators, including Gilead, Merck, Novartis, Regeneron, and Sanofi, in high-stakes intellectual property disputes.

He has extensive experience as lead counsel in high-value Hatch-Waxman patent litigations representing branded pharmaceutical companies against generic drug challengers, as well as bet-the-company patent cases involving biologics. Leveraging his litigation experience and deep industry knowledge, Brian also counsels emerging and established life sciences companies on protecting, licensing, and monetizing their IP assets.